Skip to main content
Log in

Post-marketing surveillance of quinolones 1988–1990

  • Review
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

It has been much easier to obtain original data on adverse drug reactions (ADR) of quinolones from the pharmaceutical industry than it was two years ago. This is to be welcomed and, as anticipated, the new data continue to suggest that the new 4-quinolones have an ADR profile which is very similar to that of other antimicrobials. Visual disturbance is not a prominent feature, in contrast to the ADR profile of nalidixic acid. Better definition of quinolone ADRs requires prospective study, and the results of a newly completed prescription event monitoring study are awaited with interest. The potential use of computerised databases and record linkage is examined, but at present the number of quinolone prescriptions is too small to assess documentation of serious but rare events such as convulsions. Physicians need to be aware of the limitations of current data on suspected ADRs. Further investment in computerised databases is required to satisfy the requirements for attributing causality of an event to a drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Davey PG Post-marketing surveillance of the quinolones: a view from Great Britain. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1402–1407.

    Google Scholar 

  2. Back DJ, Grimmer SFM, Orme ML'E, Proudlove C, Mann RD, Breckenridge AM Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anti-convulsants and antibiotics. British Journal of Clinical Pharmacology 1988, 25: 527–532.

    PubMed  Google Scholar 

  3. Platt R, Dreis MW, Kennedy DL, Kuritsky JN Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole. Journal of Infectious Diseases 1988, 158: 474–477.

    PubMed  Google Scholar 

  4. McDevitt DG, Beardon PHG, Brown SV Record linkage in Tayside: an assessment of present development. In: Mann RD (ed): Adverse drug reactions. Parthenon, Carnforth, 1987, p. 107–114.

    Google Scholar 

  5. Jick H The Boston Collaborative Drug Surveillance Program and the Puget Sound Health Maintenance Organization. Drug Information Journal 1985, 19: 237–242.

    Google Scholar 

  6. Shapiro S The role of automated record linkage in the postmarketing surveillance of drug safety: A critique. Clinical Pharmacology and Therapeutics 1989, 46: 371–386.

    PubMed  Google Scholar 

  7. Shapiro S Automated record linkage: A response to the commentary and letters to the editor. Clinical Pharmacology and Therapeutics 1989, 46: 395–398.

    PubMed  Google Scholar 

  8. Faich GA, Stadel BV The future of automated record linkage for postmarketing surveillance: A response to Shapiro. Clinical Pharmacology and Therapeutics 1989, 46: 387–389.

    PubMed  Google Scholar 

  9. Strom BL, Carson JL Automated data bases used for pharmacoepidemiology research. Clinical Pharmacology and Therapeutics 1989, 46: 390–394.

    PubMed  Google Scholar 

  10. Iseman MD, Miller B If a tree falls in the middle of the forest. Isoniazid and hepatitis. American Reviews of Respiratory Diseases 1989, 140: 575–576.

    Google Scholar 

  11. Moulding TS, Redeker AG, Kanel GC Twenty isoniazid-associated deaths in one state. American Reviews of Respiratory Diseases 1989, 140: 700–705.

    Google Scholar 

  12. Choe U, Rothschild BM, Laitman L Ciprofloxacin-induced vasculitis. The New England Journal of Medicine 1989, 320: 257–258.

    Google Scholar 

  13. Huminer D, Cohen JD, Majadla R, Dux S Hypersensitivity vasculitis due to ofloxacin. British Medical Journal 1989, 299: 303.

    PubMed  Google Scholar 

  14. Pace JL, Gatt P Fatal vasculitis associated with ofloxacin. British Medical Journal 1989, 299: 658.

    Google Scholar 

  15. Slama TG Serum sickness-like illness associated with ciprofloxacin. Antimicrobial Agents and Chemotherapy 1990, 34: 904–905.

    PubMed  Google Scholar 

  16. Stricker BHCh, Slagboom G, Demaeseneer R, Slootmaekers V, Thijs I, Olsson S Anaphylactic reactions to cinoxacin. British Medical Journal 1988, 297: 1434–1435.

    PubMed  Google Scholar 

  17. Rippelmeyer DJ, Synhavsky A Ciprofloxacin and allergic interstitial nephritis. Annals of Internal Medicine 1988, 109: 170.

    Google Scholar 

  18. Dan M, Samra Z Clostridium difficile colitis associated with ofloxacin therapy. American Journal of Medicine 1989, 87: 479.

    Article  Google Scholar 

  19. Segev S, Alkan M Transient mental impairment associated with quinolone therapy. Reviews of Infectious Diseases 1988, 10, Supplement 1: 262.

    Google Scholar 

  20. Alfaham M, Holt ME, Goodchild MC Arthropathy in a patient with cystic fibrosis taking ciprofloxacin. British Medical Journal 1987, 295: 699.

    PubMed  Google Scholar 

  21. Sonnenblick M, Algur N, Rosin A Thiazide-induced hyponatremia and vasopressin release. Annals of Internal Medicine 1989, 110: 751–752.

    Google Scholar 

  22. Leor J, Matetski S Ofloxacin and warfarin. Annals of Internal Medicine 1988, 109: 761.

    Google Scholar 

  23. Reiter C, Pfeiffer M, Hullman RN Brief report: Safety of ciprofloxacin based on phase IV studies (“Anwendungsbeobachtung”) in the Federal Republic of Germany. American Journal of Medicine 1989, 87, Supplement 5A: 103–106.

    Article  PubMed  Google Scholar 

  24. Inman WHW, Rawson NSB Erythromycin estolate and jaundice. British Medical Journal 1983, 286: 1954–1955.

    PubMed  Google Scholar 

  25. Smith PM, Wilton A, Routledge PA Jaundice associated with amoxycillin-clavulanate potassium therapy. European Journal of Gastroenterology and Hepatology 1991, 3: 95–96.

    Google Scholar 

  26. Iravani A, Richard GA Amoxicillin-clavulanate acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora. Antimicrobial Agents and Chemotherapy 1986, 29: 107–111.

    PubMed  Google Scholar 

  27. Reddy KR, Brilliant P, Schiff ER Amoxicillin-clavulanate potassium-associated cholestasis. Gastroenterology 1989, 86: 1135–1141.

    Google Scholar 

  28. Bigby M, Jick S, Jick H, Arndt K Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. Journal of the American Medical Association 1986, 256: 3358–3363.

    Article  PubMed  Google Scholar 

  29. Graff-Lonnevig V, Hedlin G, Lindfors A Penicillin allergy — a rare paediatric condition? Archives of Disease in Childhood 1988, 63: 1342–1346.

    PubMed  Google Scholar 

  30. Inman W No disasters — PEM News 1990, 1522: 30–31.

    Google Scholar 

  31. Boston Collaborative Drug Surveillance Program Drug-induced convulsions. Lancet 1972, September 30: 677–679.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davey, P.G., McDonald, T. & Lindsay, G. Post-marketing surveillance of quinolones 1988–1990. Eur. J. Clin. Microbiol. Infect. Dis. 10, 384–389 (1991). https://doi.org/10.1007/BF01967015

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967015

Keywords

Navigation